Search
Search
Journalism from the heart of crises
  1. Home
  2. Africa

Drug company millions pledged for AIDS

    JOHANNESBURG
    Multinational drug manufacturer, GlaxoSmithKline (GSK) has announced a US $1.6 million grant over 2 years to support an HIV/AIDS clinic in Malawi and another in Uganda. In a recent statement, GSK said the grant was part of the company's long-standing commitment to health initiatives in the developing world, and care and community assistance for people living with HIV/AIDS. The president of GSK's US operations, Chris Viehbacher, explained that the grant aimed to improve the standard of medical care provided to families, while also promoting community awareness and HIV/AIDS education. Viehbacher said: "We hope this GSK grant will help support care for the whole family ... if the family's HIV health is addressed, both parents will live longer, so that the child will be cared for."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Get the day’s top headlines in your inbox every morning

    Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

    DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

    Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

    It’s the perfect way to start your day.

    Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join